Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica

Functional Consequences of Neuromyelitis Optica-IgG Astrocyte Interactions on Blood-Brain Barrier Permeability and Granulocyte Recruitment

(2014) T. Vincent et al.   JOURNAL OF IMMUNOLOGY

The history of neuromyelitis optica

(2013) Sven Jarius et al.   Journal of Neuroinflammation

Blood-brain barrier destruction determines Fisher/Bickerstaff clinical phenotypes: an in vitro study

(2013) K. Saito et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

NMO sera down-regulate AQP4 in human astrocyte and induce cytotoxicity independent of complement

(2013) Hiroyo Haruki et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Advanced glycation end-products disrupt the blood–brain barrier by stimulating the release of transforming growth factor–β by pericytes and vascular endothelial growth factor and matrix metalloproteinase–2 by endothelial cells in vitro

(2013) Fumitaka Shimizu et al.   NEUROBIOLOGY OF AGING

Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica

(2012) Ingo Kleiter   ARCHIVES OF NEUROLOGY

Establishment and Characterization of Human Peripheral Nerve Microvascular Endothelial Cell Lines: A New in vitro Blood-Nerve Barrier (BNB) Model

(2012) Masaaki Abe et al.   CELL STRUCTURE AND FUNCTION

Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models

(2012) Yukio Takeshita et al.   IMMUNOLOGICAL REVIEWS

Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders

(2012) A. Jacob et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica

(2012) A. Uzawa et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Aquaporin 4 and neuromyelitis optica

(2012) Marios C Papadopoulos et al.   LANCET NEUROLOGY

Does natalizumab therapy worsen neuromyelitis optica?

(2012) A. Jacob et al.   NEUROLOGY

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Markedly Elevated Soluble Intercellular Adhesion Molecule 1, Soluble Vascular Cell Adhesion Molecule 1 Levels, and Blood-Brain Barrier Breakdown in Neuromyelitis Optica

(2011) Akiyuki Uzawa   ARCHIVES OF NEUROLOGY

Increased serum matrix metalloproteinase-9 in neuromyelitis optica: Implication of disruption of blood–brain barrier

(2011) Takafumi Hosokawa et al.   JOURNAL OF NEUROIMMUNOLOGY

Sera from neuromyelitis optica patients disrupt the blood–brain barrier

(2011) Fumitaka Shimizu et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures

(2011) S. Jarius et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4

(2011) Woojun Kim et al.   Multiple Sclerosis Journal

Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy

(2011) MH Barnett et al.   Multiple Sclerosis Journal

Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination

(2010) Rakhi Sharma et al.   ACTA NEUROPATHOLOGICA

Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells

(2010) Makoto Kinoshita et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice

(2010) Samira Saadoun et al.   BRAIN

Establishment of a new conditionally immortalized human brain microvascular endothelial cell line retaining an in vivo blood-brain barrier function

(2010) Yasuteru Sano et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance

(2010) Sven Jarius et al.   Journal of Neuroinflammation

AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance

(2010) Sven Jarius et al.   Nature Reviews Neurology

Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo

(2009) Monika Bradl et al.   ANNALS OF NEUROLOGY

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica

(2008) S. Jarius et al.   BRAIN